Analysts expect Maze Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00, a 100.0% miss against the 2.78 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.00 M | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | 0.00 | 0.00 | 3.61 M | 0.00 | 0.00 | 10.71 M | 2.88 M | 0.00 | 0.00 | 3.45 M | 3.82 M | 622,219.02 | -538,720.15 | 6.46 M | 2.91 M | ||||||||||
| Low Estimate | - | 0.00 | 0.00 | 3.07 M | 0.00 | 0.00 | 9.94 M | 2.67 M | 0.00 | 0.00 | 3.16 M | 3.20 M | 527,414.50 | -572,131.23 | 5.32 M | 2.57 M | ||||||||||
| Consensus Estimate | - | 0.00 | 0.00 | 3.34 M | 0.00 | 0.00 | 10.33 M | 2.78 M | 0.00 | 0.00 | 3.30 M | 3.51 M | 574,816.76 | -555,425.69 | 5.89 M | 2.74 M |
Analysts expect Maze Therapeutics, Inc. to report earnings per share of -0.80 for Q3 26, against a range of -0.84 to -0.76. The most recent reported quarter, Q2 26, came in at -0.76, a 10.1% miss against the -0.69 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -18.32 | -1.15 | -0.77 | -0.66 | -0.65 | -0.45 | -0.76 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 2.29 | -0.72 | -0.82 | -0.66 | -0.67 | -0.51 | -0.63 | -0.76 | -0.79 | -0.69 | -0.81 | -0.83 | 0.98 | 0.21 | -1.64 | ||||||||||
| Low Estimate | 1.95 | -0.78 | -0.98 | -0.80 | -0.79 | -0.59 | -0.75 | -0.84 | -0.93 | -0.79 | -0.89 | -0.89 | 0.88 | 0.19 | -1.82 | ||||||||||
| Consensus Estimate | 2.12 | -0.75 | -0.90 | -0.73 | -0.73 | -0.55 | -0.69 | -0.80 | -0.86 | -0.74 | -0.85 | -0.86 | 0.93 | 0.20 | -1.73 |
Pull Wall Street consensus for Maze Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MAZE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MAZE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MAZE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();